Inovio stock rise highlights the impact of plasmid DNA drug approval on market performance.
Read MoreNATCO Pharma Semaglutide: Clear Approval Boosts Stock by 12%
NATCO Pharma Semaglutide gains 12% after CDSCO approval in India. Discover the impact on the market and future prospects.
Read More
